You are here

Updates

Dr. Ruth Nussenzweig died on April 1, 2018 at age 89. Dr. Nussenzweig was the 2008 recipient of the Sabin Gold Medal for her pioneering research that led to the development of the RTS,S malaria vaccine.

Geneva, Switzerland – April 3, 2018 – The World Health Organization (WHO) recommends the introduction of typhoid conjugate vaccine (TCV) for infants and children over six months of age in typhoid-endemic countries. This new policy will help ensure access to typhoid vaccination in communities most impacted by the disease, which is responsible for nearly 12 million infections and between 128,000 and 161,000 deaths a year.

Dr. Albert Bruce Sabin, best known as the developer of the oral live virus polio vaccine, died 25 years ago. Over the course of a career that spanned nearly six decades, his discoveries and approaches to research shaped the modern world.

Health officials and local researchers have launched an emergency vaccination campaign to stem an outbreak of ceftriaxone-resistant typhoid in Hyderabad, Pakistan. The outbreak has sickened more than 800 people since it began in late 2016.

WASHINGTON, D.C. – January 8, 2018 – The Sabin Vaccine Institute, a non-profit global health organization dedicated to enabling vaccine innovation, making vaccines more accessible and expanding immunization across the globe, is pleased to announce a new three-year $6.6 million grant to help speed the development of next generation influenza vaccines and support related immunization issues. This work is generously supported by the Page Family Donor Advised Fund.

Geneva, Switzerland – January 3, 2018 – A typhoid conjugate vaccine has been prequalified by the World Health Organization (WHO), bringing the vaccine one step closer to reaching millions more people at risk of typhoid.